NCT00627692View on ClinicalTrials.gov

Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions

Constipation

Interventions

DRUG

Prucalopride

0.5 mg o.d.

OTHER

Placebo

o.d.

DRUG

Prucalopride

1 mg o.d.

DRUG

Prucalopride

2 mg o.d.

DRUG

Prucalopride

4 mg o.d.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Movetis

INDUSTRY